Bragar Eagel &amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive ( UNCY ) To Contact Him Directly To Discuss Their Options Before the October 14th Deadline.

UNCY

<p>Bragar Eagel & Squire, P.C. 宣佈對 Unicycive Therapeutics, Inc. 提起集體訴訟，針對在 2024 年 3 月 29 日至 2025 年 6 月 27 日期間購買股票的投資者。訴訟指控 Unicycive 在遵守 FDA 生產要求方面存在虛假陳述，導致在 FDA 負面調查後股票價格大幅下跌。投資者需在 2025 年 10 月 14 日之前申請成為主要原告。有關更多信息，受影響的投資者被鼓勵直接聯繫該律師事務所</p>

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. and Encourages Investors to Contact the Firm

UNICYCIVE 警報：Bragar Eagel & Squire, P.C. 宣佈已對 Unicycive Therapeutics, Inc.提起集體訴訟，並鼓勵投資者與該律所聯繫